Cargando…
Clinical immunobiology. Volume 4 /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Academic Press,
1980.
|
| Colección: | Clinical Immunobiology.
|
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn893722393 | ||
| 003 | OCoLC | ||
| 005 | 20231120111832.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 141025s1980 nyu ob 001 0 eng d | ||
| 040 | |a OPELS |b eng |e rda |e pn |c OPELS |d N$T |d E7B |d OCLCF |d EBLCP |d NLGGC |d OCLCQ |d YDXCP |d UAB |d DEBBG |d OCLCQ |d VLY |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 898771966 |a 948674845 |a 1162225851 | ||
| 020 | |a 9781483216355 |q (electronic bk.) | ||
| 020 | |a 1483216357 |q (electronic bk.) | ||
| 020 | |z 0120700042 | ||
| 020 | |z 9780120700042 | ||
| 035 | |a (OCoLC)893722393 |z (OCoLC)898771966 |z (OCoLC)948674845 |z (OCoLC)1162225851 | ||
| 050 | 4 | |a QR180.2 |b .C55 1980eb | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.07/9 |2 23 |
| 245 | 0 | 0 | |a Clinical immunobiology. |n Volume 4 / |c edited by Fitz H. Bach, Robert A. Good. |
| 264 | 1 | |a New York : |b Academic Press, |c 1980. | |
| 300 | |a 1 online resource (xxii, 198 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Clinical Immunobiology ; |v v. 4 | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Clinical Immunobiology; Copyright Page; Table of Contents; List of Contributors; Preface; Contents of Previous Volumes; Chapter 1. General Orientation of Human Lymphocyte Subpopulations; I. Introduction; II. Cytoplasmic Immunoglobulin; III. Membrane Immunoglobulin; IV. la System; V. Epstein-Barr Virus (EBV) Receptor; VI. Complement Receptors; VII. Receptors for Fc Region of Immunoglobulins; VIII. Enzymatic Markers; IX. Receptors for Peanut Agglutinin; X. Erythrocyte Receptors; XI Surface Antigens of Lymphocyte Subpopulations Defined by Monoclonal Antibodies. | |
| 505 | 8 | |a XII. Relationship between Ty Cells and MonocytesXIII. Distinction of Lymphocytes from Monocytes; XIV. The Third-Cell Population or Unclassified Lymphoid Cells; XV. Summary; References; Chapter 2. Lymphocyte Membrane Complement Receptors; I. Introduction; II. Methods for Detection of C Receptors; III. Expression of C Receptors and Other Surface Markers on Normaland Leukemic Human Lymphocytes; IV. Interpretation and Significance; References; Chapter 3. Regulatory Human T-Cell Subpopulations Defined by Receptors for IgG or IgM; I. Introduction; II. Enumeration and Isolation of T.M and T.G Cells. | |
| 505 | 8 | |a III. Morphology of T.M and T.G CellsIV. Tissue Distribution of T.M and T.G Cells; V. Functional Analysis of T.M and T.G Cells; VI. Clinical Relevance of T.M and T.G Subpopulations; Selected Reading; Addendum; Chapter 4. Mitogens; I. Introduction; II. Fundamentals of Lectin-Induced Mitogenesis; III. Procedure for Determining in Vitro Lectin-induced Activation of Lymphocytes; IV. Clinical Usefulness of Lectins; General Reading References; Chapter 5. Natural Killer Cells and Cells Mediating Antibody-Dependent Cytotoxicity against Tumors; I. Introduction; II. Methods. | |
| 505 | 8 | |a III. Characteristics of NK Cells and Their Relationship to K CellsIV. Specificity of Natural Cytotoxicity; V. Factors Affecting Levels of NK and K Cell Activities; VI. Possible Clinical Significance of These Effector Cells; References; Chapter 6. Regulation of the Immune System by Lymphocyte Sets: Analysis in Animal Models; I. General Considerations; II. Analysis in the Mouse; III. Conclusions; Selected References; Chapter 7. The Serology of HLA-A, -B, and -C; I. Introduction; II. Experimental Methods and Findings; III. Conclusions; References; Chapter 8. The Serology of HLA-DR. | |
| 505 | 8 | |a I. IntroductionII. Technical Considerations; III. Results; IV. Discussion; References; Chapter 9. Cellular Immunogenetics-Definition of HLA-D Region Encoded Antigens by T Lymphocyte Reactivities; I. Introduction; II. Mixed Leukocyte Culture with Homozygous Typing Cells; III. Primed LD-Typing (PLT); IV. General Discussion; References; Chapter 10. Cell-Mediated Lympholysis; I. Introduction; II. Terminology; III. Technique; V. Genetic Control of CML; VI. Cell-Mediated Lympholysis Typing; VII. Preliminary Information from CML Typing Experiments; VIII. Future Prospects; Suggested Reading List. | |
| 546 | |a English. | ||
| 650 | 0 | |a Immunologic diseases. | |
| 650 | 0 | |a Immunology. | |
| 650 | 0 | 2 | |a Allergy and Immunology |0 (DNLM)D000486 |
| 650 | 2 | |a Immune System Diseases |0 (DNLM)D007154 | |
| 650 | 6 | |a Maladies immunologiques. |0 (CaQQLa)201-0007315 | |
| 650 | 6 | |a Immunologie. |0 (CaQQLa)201-0066630 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Immunologic diseases |2 fast |0 (OCoLC)fst00967977 | |
| 650 | 7 | |a Immunology |2 fast |0 (OCoLC)fst00968006 | |
| 700 | 1 | |a Bach, Fritz H., |e editor. | |
| 700 | 1 | |a Good, Robert A., |d 1922-2003, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Clinical immunobiology / Vol. 4 |z 0120700042 |w (OCoLC)725851292 |
| 830 | 0 | |a Clinical Immunobiology. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780120700042 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00971014/4 |z Texto completo |